Biotech

All Articles

Novo inks $600M NanoVation bargain to analyze hereditary medicines ex-liver

.Novo Nordisk is actually proceeding its push in to hereditary medicines, consenting to compensate N...

Innovent links cytokine to colorectal cancer cells actions

.Innovent Biologics has made the scenario that its own gate inhibitor-cytokine blend protein possess...

Merck, Daiichi ADC hits goal in phase 3 bronchi cancer cells research

.A stage 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina deepens AI focus along with collab to select cancer cells aim ats

.Five months after Rakovina Therapies pivoted toward expert system, the cancer-focused biotech has a...

Ascendis' dwarfism medication smash hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually become a prospective risk to BioMarin's Voxzogo, reporting stage 3 dev...

Despite ph. 3 skip, Alkeus finds path ahead for eye condition possession

.Though Alkeus Pharmaceuticals' dental eye ailment resource neglected to significantly reduce geogra...

Kairos goes social along with $6M IPO to fund tests of cancer medication

.With a triad of biotechs attacking the Nasdaq on Friday, it was actually easy to skip a smaller-sca...

Vaccine and also Keytruda combination successful in squamous cell carcinoma

.Immune system gate inhibitors are the superheroes of cancer treatment. Medications like Bristol Mye...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings an...

Regeneron's Opdualag rival reveals 57% feedback price

.Regeneron is back with long-lasting follow-up for its LAG-3 inhibitor and PD-1 inhibitor combo in s...